Regulations.gov document
Guidance for Industry; Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs…
Other · FDA-2013-D-1464 · posted Dec 4, 2013
Key facts
| Document ID | FDA-2013-D-1464-0002 |
|---|---|
| Title | Guidance for Industry; Bioequivalence Studies With Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2013-D-1464 |
| Posted | Dec 4, 2013 |
| Comment period opens | Dec 4, 2013 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: